Literature DB >> 18258363

c-Jun N-terminal kinase and p38 mitogen-activated protein kinase mediate double-strand RNA-induced inducible nitric oxide synthase expression in microglial cells.

Pil-Jae Kong1, Hee Jae Lee, Sang-Hyun Lee, Su Young Kim, Su Nam Lee, Wan-Joo Chun, Sung-Soo Kim.   

Abstract

Double-stranded RNA (dsRNA) has been implicated as a potential immune stimulant in activating microglia, which can cause chronic neurodegeneration. In this study, we examined the involvement of different types of mitogen-activated protein kinases (MAPKs) in the induction of inducible nitric oxide synthase (iNOS) by dsRNA in microglial cells. Nitric oxide production was increased after exposure of microglia to 50mug/mL dsRNA. Levels of dsRNA-induced nitrite production in a line of immortalized murine microglia (BV2) and in primary cultures of murine microglia were decreased by inhibition of JNK or p38 MAPK, but were increased by inhibition of extracellular signal-regulated kinase. Similar results were shown in the levels of dsRNA-induced iNOS gene expression in BV2 cells. Phosphorylation levels of p38 MAPK were increased, depending on p38 MAPK inhibitor concentrations, while activation levels of MAPKAPK2, a known p38 substrate, were inhibited. Thus, it is likely that SB203580 inhibited the kinase activity of p38 MAPK, resulting in the loss of a feedback inhibition regulatory loop of p38 MAPK in BV2 cells. These findings suggest that dsRNA stimulated iNOS expression via MAPK signaling pathways, including JNK and p38 MAPK.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258363     DOI: 10.1016/j.neulet.2007.10.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Deoxynivalenol induces p38 interaction with the ribosome in monocytes and macrophages.

Authors:  Hee Kyong Bae; James J Pestka
Journal:  Toxicol Sci       Date:  2008-05-22       Impact factor: 4.849

2.  Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment.

Authors:  Shannon Dallas; Michelle L Block; Deborah M Thompson; Marcelo G Bonini; Patrick T Ronaldson; Reina Bendayan; David S Miller
Journal:  J Neuroinflammation       Date:  2013-05-04       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.